The selection of target areas for orbital imaging, application of diethylenetriaminepentaacetic acid orbital imaging, clinical factors, alkaline phosphatase, and thyrotropin receptor antibodies in the staging and grading of thyroid-associated ophthalmopathy

MLA

Yuan, Min, et al. “The Selection of Target Areas for Orbital Imaging, Application of Diethylenetriaminepentaacetic Acid Orbital Imaging, Clinical Factors, Alkaline Phosphatase, and Thyrotropin Receptor Antibodies in the Staging and Grading of Thyroid-Associated Ophthalmopathy.” Nuclear Medicine Communications, vol. 46, no. 2, Feb. 2025, pp. 152–61. EBSCOhost, https://doi.org/10.1097/MNM.0000000000001934.

APA

Yuan, M., Feng, Y., Guo, L., Li, P., Liu, Y., Wang, Y., Chen, Y., & Jin, G. (2025). The selection of target areas for orbital imaging, application of diethylenetriaminepentaacetic acid orbital imaging, clinical factors, alkaline phosphatase, and thyrotropin receptor antibodies in the staging and grading of thyroid-associated ophthalmopathy. Nuclear Medicine Communications, 46(2), 152–161. https://doi.org/10.1097/MNM.0000000000001934

Chicago

Yuan, Min, Yiren Feng, Lin Guo, Ping Li, Yuting Liu, Yao Wang, Yusong Chen, and Gang Jin. 2025. “The Selection of Target Areas for Orbital Imaging, Application of Diethylenetriaminepentaacetic Acid Orbital Imaging, Clinical Factors, Alkaline Phosphatase, and Thyrotropin Receptor Antibodies in the Staging and Grading of Thyroid-Associated Ophthalmopathy.” Nuclear Medicine Communications 46 (2): 152–61. doi:10.1097/MNM.0000000000001934.